AXSM
Axsome TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AXSM Profile
Axsome Therapeutics, Inc.
A biopharmaceutical company that develops novel therapies for the management of central nervous system (CNS) disorders
22 Cortlandt Street, 16th Floor, New York, New York 10007
--
Axsome Therapeutics, Inc., was founded in January 2012. The company is a clinical-stage biopharmaceutical company developing novel treatments for pain and other central nervous system or central nervous system, disease management. By focusing on this therapeutic area, they are addressing a significant and growing market where current therapeutic options are limited or insufficient. Their goal is to become a fully integrated biopharmaceutical company to develop and commercialize extended treatment options for healthcare professionals to improve life differentiation therapy for patients with pain and other CNS diseases.
